Crossmark Global Holdings Inc. purchased a new position in shares of Analogic Co. (NASDAQ:ALOG) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 2,986 shares of the medical research company’s stock, valued at approximately $250,000.

A number of other large investors have also recently added to or reduced their stakes in ALOG. Vanguard Group Inc. lifted its position in Analogic by 3.1% during the 2nd quarter. Vanguard Group Inc. now owns 1,147,408 shares of the medical research company’s stock worth $83,359,000 after acquiring an additional 34,765 shares during the period. Dimensional Fund Advisors LP lifted its position in Analogic by 18.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 910,561 shares of the medical research company’s stock worth $66,153,000 after acquiring an additional 143,003 shares during the period. Wells Fargo & Company MN lifted its position in Analogic by 1.8% during the 2nd quarter. Wells Fargo & Company MN now owns 785,205 shares of the medical research company’s stock worth $57,045,000 after acquiring an additional 14,180 shares during the period. Northern Trust Corp lifted its position in Analogic by 53.5% during the 2nd quarter. Northern Trust Corp now owns 372,687 shares of the medical research company’s stock worth $27,075,000 after acquiring an additional 129,855 shares during the period. Finally, State Street Corp lifted its position in Analogic by 6.1% during the 2nd quarter. State Street Corp now owns 345,329 shares of the medical research company’s stock worth $25,086,000 after acquiring an additional 19,796 shares during the period. Hedge funds and other institutional investors own 97.58% of the company’s stock.

A number of analysts have weighed in on ALOG shares. Zacks Investment Research raised Analogic from a “hold” rating to a “buy” rating and set a $93.00 price objective for the company in a research report on Tuesday, October 10th. Jefferies Group reissued a “hold” rating and issued a $75.00 price target on shares of Analogic in a report on Wednesday, September 20th. Four investment analysts have rated the stock with a hold rating, The company presently has an average rating of “Hold” and an average price target of $85.25.

Analogic Co. (NASDAQ ALOG) opened at $82.15 on Friday. The stock has a market capitalization of $1,020.00, a price-to-earnings ratio of 49.29, a P/E/G ratio of 4.22 and a beta of 0.85. Analogic Co. has a 1-year low of $66.00 and a 1-year high of $93.55.

COPYRIGHT VIOLATION NOTICE: This story was first posted by Daily Political and is the property of of Daily Political. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/12/02/crossmark-global-holdings-inc-purchases-new-position-in-analogic-co-alog.html.

Analogic Company Profile

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Institutional Ownership by Quarter for Analogic (NASDAQ:ALOG)

Receive News & Ratings for Analogic Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Co. and related companies with MarketBeat.com's FREE daily email newsletter.